Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma

Autor: Matthew C. Biagioli, Kamran Ahmed, John E. Mullinax, Ricardo J. Gonzalez, Douglas Letson, Louis B. Harrison, Jonathan S. Zager, Odion Binitie, Young Chul Kim, Jacob G. Scott, Yazan Abuodeh, Marilyn M. Bui, Amarjit S. Saini, Arash O. Naghavi, Daniel C. Fernandez
Rok vydání: 2016
Předmět:
Chronic wound
Male
Time Factors
medicine.medical_treatment
Fibrosarcoma
Brachytherapy
Soft Tissue Neoplasms
Surgical Flaps
030218 nuclear medicine & medical imaging
0302 clinical medicine
Aged
80 and over

Soft tissue sarcoma
Margins of Excision
Radiotherapy Dosage
Sarcoma
Liposarcoma
Middle Aged
Oncology
030220 oncology & carcinogenesis
Female
medicine.symptom
Adult
medicine.medical_specialty
Myxosarcoma
Article
03 medical and health sciences
Young Adult
Negative-pressure wound therapy
medicine
Humans
Radiology
Nuclear Medicine and imaging

Aged
Retrospective Studies
Wound Healing
Wound dehiscence
business.industry
Retrospective cohort study
Extremities
Plastic Surgery Procedures
medicine.disease
Surgery
Amputation
Multivariate Analysis
Radiotherapy
Adjuvant

Neoplasm Recurrence
Local

business
Negative-Pressure Wound Therapy
Follow-Up Studies
Zdroj: Brachytherapy
ISSN: 1873-1449
Popis: Purpose Prior studies illustrated a reduction in wound complications with the use of staged reconstruction (SR) and negative pressure wound therapy when treating soft tissue sarcoma (STS) with surgical resection followed by high-dose-rate adjuvant brachytherapy. The purpose of this study is to compare the outcomes of SR and immediate reconstruction (IR) brachytherapy in recurrent STS. Methods and Materials A retrospective review of 40 patients with recurrent STS of the local extremity and trunk treated with resection followed by adjuvant brachytherapy alone. Margin status was defined as positive (SM(+)) if there was microscopic involvement (R1) or ≤1 mm margin and negative (SM(−)) if >1 mm margin was obtained. SR and IR were compared regarding toxicity, local control, and limb preservation. Results Median followup was 27 months. When comparing the SR (n = 22) and IR (n = 18) cohorts, there was a significantly lower final SM(+) rate in SR (32% vs. 83%, p < 0.01). A 2-year local control benefit seen with SR (80% vs. 34%; p = 0.012) and a final SM(−) (81% vs. 39%; p = 0.023). SR was associated with less toxicity on multivariate analysis, including a 90% decrease in persistent edema, an 80% decrease in wound dehiscence, and a 94% decrease in nonhealing wounds, when compared to IR. Ten of 31 (32%) extremity cases required eventual amputation from either chronic wound complications (n = 4) or local recurrence (n = 6). SR predicted for a benefit in 2-year limb preservation (88% vs. 50%; p = 0.008). Conclusion In our series, the treatment with SR brachytherapy resulted in less morbidity and an improved final SM(−) rate. This technique translated to an improvement in both local control and limb preservation of recurrent STS.
Databáze: OpenAIRE